← Leaderboards
Jody R Piltz-Seymour
University Of Pennsylvania
$811,727
Attributed
$811,727
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$811,727 · 1
By mechanism
U10$811,727 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Mortimer Mordecai Civan$7,951,755
- Claire H Mitchell$12,533,302
- Leszek K Kubin$12,685,863
- Rob R Macgregor$4,980,820
- Andras Komaromy$6,828,118
Others in their field
Top investigators on “Beta Antiadrenergic Agent”
- Christopher M O'Connor · Duke University$18,508,673
- Michael A Kass · Washington University$9,081,282
- Bruce M Psaty · University Of Washington$5,047,845
- Kenneth Allen Holroyd · Ohio University Athens$2,665,090
- Jeffrey H Silverstein · Mount Sinai School Of Medicine Of Nyu$2,655,974
- Susan Heckbert · University Of Washington$2,562,214
Research focus
Beta Antiadrenergic AgentStatistics /BiometryMioticDisease /Disorder Proneness /RiskDrug Adverse EffectDosageDrug Administration RoutesEarly DiagnosisEpinephrineEye Disorder ChemotherapyEye Fundus PhotographyEye PharmacologyGlaucomaGlaucoma TestHuman SubjectHuman Therapy EvaluationIntraocular PressureLongitudinal Human StudyMass ScreeningMedical ComplicationOptic DiskPilocarpinePrognosisTherapy Compliance
Grant awards (6)
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$134,931
U10 · FY2005 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$131,862
U10 · FY2004 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$149,652
U10 · FY2003 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$146,782
U10 · FY2002 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$125,750
U10 · FY2001 · EY
OCULAR HYPERTENSION TREATMENT STUDY (OHTS)$122,750
U10 · FY2000 · EY